VATENYSEFabricated Structural Metal ProductsFiscal year ends December 31
INNOVATE Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$5.95−0.05 (-0.83%)
Close on Oct 19, 2026
- Market cap
- $83.11M
- P/E (TTM)
- –
- Dividend yield
- –
INNOVATE Corp. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infrastructure | $1.48B | $1.30B | $1.21B | $1.06B | $956.50M | $1.03B | $1.07B | $1.20B | $1.34B | $1.39B | $1.40B | $1.44B | 97.9% | +55.2% |
| Spectrum Segment | $22.00M | $22.30M | $23.20M | $24.30M | $25.10M | $25.60M | $25.70M | $24.60M | $23.60M | $23.10M | $22.50M | $27.50M | 1.5% | -12.4% |
| Life Sciences | $10.00M | $11.00M | $12.50M | $13.50M | $13.40M | $11.90M | $9.80M | $7.20M | $4.80M | – | $3.30M | – | 0.7% | -25.4% |
| Life Sciences | – | – | – | – | – | – | – | – | $4.80M | $3.80M | $3.30M | $3.10M | – | – |
| Operating income | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Infrastructure | $91.20M | $62.30M | $55.40M | $44.30M | $40.60M | $65.50M | $65.70M | $79.60M | $88.20M | $67.40M | $64.40M | $57.20M | +124.6% |
| Spectrum Segment | -$2.00M | -$700.00K | -$100.00K | $1.00M | $1.00M | $1.40M | $1.40M | $0 | -$2.00M | -$2.70M | -$3.40M | -$2.90M | -300.0% |
| Life Sciences | -$8.00M | -$10.10M | -$10.90M | -$12.20M | -$12.70M | -$13.90M | -$14.10M | -$13.90M | -$13.90M | – | -$15.00M | – | -37.0% |
| Other | – | – | – | – | – | – | – | -$1.20M | -$1.20M | -$1.70M | -$3.10M | -$2.10M | – |
| Life Sciences | – | – | – | – | – | – | – | – | -$13.90M | -$13.80M | -$15.00M | -$16.00M | – |
By product or service
By region
From the segment and revenue-disaggregation notes of Innovate's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.